ES2193201T3 - Agentes antibacterianos tipo oxazolidonas sustituidas con oxazina y tiazina biciclica. - Google Patents
Agentes antibacterianos tipo oxazolidonas sustituidas con oxazina y tiazina biciclica.Info
- Publication number
- ES2193201T3 ES2193201T3 ES95938148T ES95938148T ES2193201T3 ES 2193201 T3 ES2193201 T3 ES 2193201T3 ES 95938148 T ES95938148 T ES 95938148T ES 95938148 T ES95938148 T ES 95938148T ES 2193201 T3 ES2193201 T3 ES 2193201T3
- Authority
- ES
- Spain
- Prior art keywords
- thiazine
- oxazine
- bicycle
- oxazolidones
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical group N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 title abstract 2
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- NCTCGHLIHJJIBK-UHFFFAOYSA-N 3-phenyl-1,3-oxazolidin-2-one Chemical class O=C1OCCN1C1=CC=CC=C1 NCTCGHLIHJJIBK-UHFFFAOYSA-N 0.000 abstract 1
- 241001112696 Clostridia Species 0.000 abstract 1
- 241000186359 Mycobacterium Species 0.000 abstract 1
- 241000186367 Mycobacterium avium Species 0.000 abstract 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 241001148470 aerobic bacillus Species 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Abstract
COMPUESTOS DE FENILOXAZOLIDINONA DE FORMULA (I) O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE OS MISMOS CARACTERIZADOS POR UN SUSTITUYENTE DE TIAZINA U OXAZINA BICICLICA. LOS COMPUESTOS SON UTILES COMO AGENTES ANTIMICROBIANOS, EFECTIVOS FRENTE A UN NUMERO DE PATOGENOS HUMANOS Y VETERINARIOS, INCLUYENDO BACTERIAS AEROBICAS GRAM-POSITIVAS COMO ESTAFILOCOCOS MULTI-RESISTENTES, ESTREPTOCOCOS Y ENTEROCOCOS ASI COMO ORGANISMOS ANAEROBIOS COMO ESPECIES DE BACTEROIDES SPP. Y CLOSTRIDIA SPP. Y ORGANISMOS DE ACIDO RAPIDO COMO MYCOBACTERIUM TUBERCULOSIS, MYCOBACTERIUM AVIUM Y MYCOBACTERIUM SPP.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33997994A | 1994-11-15 | 1994-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2193201T3 true ES2193201T3 (es) | 2003-11-01 |
Family
ID=23331388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95938148T Expired - Lifetime ES2193201T3 (es) | 1994-11-15 | 1995-10-31 | Agentes antibacterianos tipo oxazolidonas sustituidas con oxazina y tiazina biciclica. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5952324A (es) |
EP (1) | EP0792273B1 (es) |
JP (1) | JPH10508844A (es) |
KR (1) | KR100392216B1 (es) |
CN (1) | CN1046520C (es) |
AT (1) | ATE233766T1 (es) |
AU (1) | AU702733B2 (es) |
BR (1) | BR9509673A (es) |
DE (1) | DE69529838T2 (es) |
DK (1) | DK0792273T3 (es) |
ES (1) | ES2193201T3 (es) |
MX (1) | MX9703543A (es) |
NO (1) | NO972222D0 (es) |
NZ (1) | NZ295528A (es) |
PT (1) | PT792273E (es) |
RU (1) | RU2128660C1 (es) |
WO (1) | WO1996015130A1 (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6964096A (en) * | 1995-09-15 | 1997-04-01 | Pharmacia & Upjohn Company | Aminoaryl oxazolidinone n-oxides |
ZA968661B (en) * | 1995-11-17 | 1998-04-14 | Upjohn Co | Oxazolidinone antibacterial agent with tricyclic substituents. |
GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
EP1114819B1 (en) * | 1996-04-11 | 2008-01-09 | Pharmacia & Upjohn Company LLC | Process to prepare oxazolidinones |
GB9609919D0 (en) * | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
KR100307211B1 (ko) * | 1997-05-24 | 2001-11-30 | 손 경 식 | 옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물 |
GB9717807D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
KR100467309B1 (ko) * | 1997-09-04 | 2005-07-18 | 씨제이 주식회사 | 옥사졸리디논유도체및그의제조방법및항균제조성물 |
KR100463111B1 (ko) * | 1997-10-30 | 2005-06-13 | 씨제이 주식회사 | 신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물 |
GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
WO1999064417A2 (en) * | 1998-06-05 | 1999-12-16 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
US6608081B2 (en) | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
US6413981B1 (en) * | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
US6518285B2 (en) | 1999-12-21 | 2003-02-11 | Ortho Mcneil Pharmaceutical, Inc. | Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
HUP0203869A2 (hu) * | 1999-12-21 | 2003-07-28 | Pharmacia & Upjohn Co. | Szulfoximin funkcionalitással rendelkező oxazolidinok és alkalmazásuk mikrobaellenes szerként, a vegyületeket tartalmazó gyógyszerkészítmények |
GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
US6833453B2 (en) | 2000-10-17 | 2004-12-21 | Pharmacia & Upjohn Company | Methods of producing oxazolidinone compounds |
DE60212959T2 (de) * | 2001-04-07 | 2007-02-15 | Astrazeneca Ab | Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika |
GB0108793D0 (en) * | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
US6887995B2 (en) * | 2001-04-20 | 2005-05-03 | Pharmacia & Upjohn Company | Process to prepare oxazolidinones |
TW200302095A (en) * | 2002-01-25 | 2003-08-01 | Upjohn Co | Oxazolidinone cotherapy |
US7141588B2 (en) | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
AR038536A1 (es) | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
JP2005527575A (ja) * | 2002-03-29 | 2005-09-15 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 糖尿病性足病変感染を治療するためのオキサゾリジノンの非経口、静脈内および経口投与 |
JP2005537301A (ja) * | 2002-08-12 | 2005-12-08 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N−アリール−2−オキサゾリジノン類及びそれらの誘導体 |
ES2271660T3 (es) * | 2002-11-21 | 2007-04-16 | PHARMACIA & UPJOHN COMPANY LLC | Derivados de n-(4-piperazin-1-il)-fenil-2-oxazolidinona-5-carboxamida y compuestos relacionados como agentes antibacterianos. |
BRPI0407304A (pt) * | 2003-02-07 | 2006-01-10 | Warner Lambert Co | Agentes antibacterianos |
JP2006516991A (ja) * | 2003-02-07 | 2006-07-13 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 抗菌剤 |
US20040204463A1 (en) * | 2003-04-01 | 2004-10-14 | Harris Christina Renee | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
US7304050B2 (en) | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
ZA200610270B (en) * | 2004-05-17 | 2008-06-25 | Acadia Pharm Inc | Androgen receptor modulators and method of treating disease using the same |
US20070004679A1 (en) * | 2004-05-17 | 2007-01-04 | Nathalie Schlienger | Androgen receptor modulators and methods of treating disease using the same |
US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
MX2007001568A (es) * | 2004-08-06 | 2007-04-16 | Pharmacia & Upjohn Co Llc | Oxindol oxazolidinonas como agentes antibacterianos. |
EP1842226B2 (en) | 2004-11-03 | 2014-07-02 | Iris International, Inc. | Homogeneous analyte detection |
EP2302078B1 (en) | 2004-11-03 | 2015-07-15 | Iris Molecular Diagnostics, Inc. | Microbubbles for affinity concentration |
US20060173037A1 (en) * | 2005-01-10 | 2006-08-03 | Nathalie Schlienger | Aminophenyl derivatives as selective androgen receptor modulators |
CA2594340C (en) * | 2005-01-10 | 2015-11-10 | Acadia Pharmaceuticals Inc. | Aminophenyl derivatives as selective androgen receptor modulators |
DK1899331T3 (da) | 2005-06-29 | 2010-03-08 | Pharmacia & Upjohn Co Llc | Homomorpholinoxazolidnoner som antibakterielle midler |
US7666864B2 (en) * | 2008-03-26 | 2010-02-23 | Global Alliance For Tb Drug Development | Bicyclic nitroimidazole-substituted phenyl oxazolidinones |
EP3316969B1 (en) | 2015-07-02 | 2022-03-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
ES2897973T3 (es) * | 2015-07-17 | 2022-03-03 | The Global Alliance For Tb Drug Dev Inc | Feniloxazolidinonas sustituidas para terapia antimicrobiana |
EP3472158A1 (en) | 2016-06-16 | 2019-04-24 | Janssen Sciences Ireland Unlimited Company | Heterocyclic compounds as antibacterials |
KR20190121315A (ko) | 2017-03-01 | 2019-10-25 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 병용 요법 |
WO2020147504A1 (en) * | 2019-01-18 | 2020-07-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
WO2020234636A1 (en) | 2019-05-17 | 2020-11-26 | Cadila Healthcare Limited | Novel compounds for the treatment of mammalian infections |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921869A (en) * | 1987-10-09 | 1990-05-01 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4801600A (en) * | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
CA1320730C (en) * | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
ATE95176T1 (de) * | 1987-10-21 | 1993-10-15 | Du Pont Merck Pharma | Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel. |
US4948801A (en) * | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
JP2865211B2 (ja) * | 1988-09-15 | 1999-03-08 | ファルマシア・アンド・アップジョン・カンパニー | 5’―インドリニル―5β―アミドメチルオキサゾリジン―2―オン類、3―(縮合環置換)フェニル―5β―アミドメチルオキサゾリジン―2―オン類および3―(窒素原子置換)フェニル―5β―アミドメチルオキサゾリジン―2―オン類 |
JP3176626B2 (ja) * | 1991-11-01 | 2001-06-18 | ファルマシア・アンド・アップジョン・カンパニー | 抗菌剤として有用な置換アリール−およびヘテロアリールフェニルオキサゾリジノン類 |
SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
MY115155A (en) * | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
ES2133588T3 (es) * | 1993-11-22 | 1999-09-16 | Upjohn Co | Esteres de hidroxiacetil-piperazin-fenil-oxazolidinonas sustituidas. |
US5668286A (en) * | 1994-03-15 | 1997-09-16 | Pharmacia & Upjohn Company | Oxazolidinone derivatives and pharmaceutical compositions containing them |
-
1995
- 1995-10-31 JP JP8516040A patent/JPH10508844A/ja active Pending
- 1995-10-31 BR BR9509673A patent/BR9509673A/pt not_active Application Discontinuation
- 1995-10-31 KR KR1019970703234A patent/KR100392216B1/ko not_active IP Right Cessation
- 1995-10-31 AT AT95938148T patent/ATE233766T1/de not_active IP Right Cessation
- 1995-10-31 MX MX9703543A patent/MX9703543A/es not_active IP Right Cessation
- 1995-10-31 PT PT95938148T patent/PT792273E/pt unknown
- 1995-10-31 WO PCT/US1995/012751 patent/WO1996015130A1/en active IP Right Grant
- 1995-10-31 NZ NZ295528A patent/NZ295528A/xx unknown
- 1995-10-31 CN CN95196252A patent/CN1046520C/zh not_active Expired - Fee Related
- 1995-10-31 DE DE69529838T patent/DE69529838T2/de not_active Expired - Fee Related
- 1995-10-31 AU AU38890/95A patent/AU702733B2/en not_active Ceased
- 1995-10-31 ES ES95938148T patent/ES2193201T3/es not_active Expired - Lifetime
- 1995-10-31 RU RU97110168A patent/RU2128660C1/ru not_active IP Right Cessation
- 1995-10-31 US US09/051,466 patent/US5952324A/en not_active Expired - Fee Related
- 1995-10-31 EP EP95938148A patent/EP0792273B1/en not_active Expired - Lifetime
- 1995-10-31 DK DK95938148T patent/DK0792273T3/da active
-
1997
- 1997-05-14 NO NO972222A patent/NO972222D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX9703543A (es) | 1997-08-30 |
DE69529838D1 (de) | 2003-04-10 |
ATE233766T1 (de) | 2003-03-15 |
DK0792273T3 (da) | 2003-06-16 |
DE69529838T2 (de) | 2003-11-13 |
CN1163615A (zh) | 1997-10-29 |
NO972222L (no) | 1997-05-14 |
WO1996015130A1 (en) | 1996-05-23 |
KR100392216B1 (ko) | 2003-10-17 |
AU702733B2 (en) | 1999-03-04 |
JPH10508844A (ja) | 1998-09-02 |
NO972222D0 (no) | 1997-05-14 |
BR9509673A (pt) | 1997-09-30 |
EP0792273A1 (en) | 1997-09-03 |
US5952324A (en) | 1999-09-14 |
PT792273E (pt) | 2003-06-30 |
AU3889095A (en) | 1996-06-06 |
NZ295528A (en) | 1999-03-29 |
CN1046520C (zh) | 1999-11-17 |
RU2128660C1 (ru) | 1999-04-10 |
EP0792273B1 (en) | 2003-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2193201T3 (es) | Agentes antibacterianos tipo oxazolidonas sustituidas con oxazina y tiazina biciclica. | |
LV12605A (en) | Substituted oxazine and thiazine oxazlidinone antimicrobials | |
DE69522234D1 (de) | Phenyloxazolidinone mit antimikrobieller wirkung | |
BR0112826A (pt) | Derivados da oxazolidinona como antimicrobianos | |
ZA968661B (en) | Oxazolidinone antibacterial agent with tricyclic substituents. | |
PT640077E (pt) | Oxazolidinonas contendo uma porcao diazina substituida e a sua utilizacao como antimicrobianos | |
ATE257829T1 (de) | Aminoaryl oxazolidinone n-oxide | |
PH19293A (en) | Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof | |
WO2003007870A3 (en) | Oxazolidinone derivatives as antimicrobials | |
ES2185800T3 (es) | Agentes antibacterianos basados en 5-amidometilo, 3-arilo butirolactona alfa, beta saturada e insaturada. | |
MX9703040A (es) | Antimicrobianos de feniloxazolidinona. | |
FR2267791B1 (es) |